Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    


AMA announces CPT update to COVID-19 vaccine booster


 

New code for Janssen booster added to codes created for Moderna and Pfizer boosters

The American Medical Association (AMA) announced that the Current Procedural Terminology (CPT®) code set has been updated by the CPT Editorial Panel to include a new code for booster doses of COVID-19 vaccine created by Janssen Pharmaceutical Companies of Johnson & Johnson.

The new CPT code for the booster dose of the Janssen COVID-19 vaccine joins unique CPT codes previously issued to COVID-19 vaccine booster doses from Moderna and Pfizer. The CPT codes for reporting COVID-19 vaccine boosters from Janssen and Moderna are effective for use as of Oct. 20. The CPT codes for the Pfizer boosters were made effective on Sept. 22. As with all the CPT codes related to COVID-19 vaccines, the effective dates coincide with the emergency use authorization issued by U.S. Food and Drug Administration (FDA).

"We believe the FDA's authorization and the CDC's recommendations in support of booster doses, including the option to mix-and-match boosters with authorized vaccines, will help provide continued protection against COVID-19 for those who need it most," said AMA President Gerald E. Harmon, M.D.

The mix and match option for authorized COVID-19 vaccines and boosters provides needed flexibility for efficient and effective vaccination programs. The CPT code set is prepared to support this strategy with product-specific CPT codes that clinically distinguished each coronavirus vaccine and booster to facilitate tracking, reporting and analysis that is needed for data-driven planning and allocation as booster programs ramp up.

For quick reference, the new code assigned to the Janssen booster for the COVID-19 vaccine is:

0034A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; booster dose

Short, medium and long descriptors for all the new vaccine-specific CPT codes can be accessed on the AMA website, along with other recent modifications to the CPT code set that have helped streamline the public health response to the SARS-CoV-2 virus and the COVID-19 disease.

To help ensure accurate coding and reporting of COVID-19 vaccines and immunization services, the AMA offers a vaccine code finder resource to help identify the appropriate CPT code combination for the type and dose of COVID-19 vaccine provided to each patient.

Changes to the CPT code set are considered through an open editorial process managed by the CPT Editorial Panel that collects broad input from the health care community and beyond to ensure CPT content reflects the coding demands of digital health, precision medicine, augmented intelligence, and other aspects of a modern health care system. This rigorous editorial process keeps the CPT code set current with contemporary medical science and technology so it can fulfill its vital role as the trusted language of medicine today and the code to its future.

 
Share:

Related Articles:


Recent Articles

Tivity Health Takes Meaningful Steps to Keep Seniors Engaged, Connected

At first glance, SilverSneakers might appear to be 'just' a fitness class ... but dig a bit deeper, and it's clear this class is actually a community keeping participants active and engaged.

Read More

AMA Adopts Policy to Combat Public Health Disinformation by Health Care Professionals

New policy aims to address spread of rampant disinformation amid COVID-19 pandemic

Read More

AMA Adopts Policy Aimed at Strengthening U.S. Public Health Infrastructure, Opposing Limits Placed on Public Health Officials

New policy calls for consistent, sustainable funding, a robust public health workforce, and data modernization

Read More

Managing Risk of Cyber Incidents

Cyber threats are here to stay -- and they continue to be one of the topics keeping senior management up at night. With breaches and ransomware attacks still occurring at high rates, the healthcare industry continues to be significantly impacted.

Read More

American Cancer Society, Meharry Team Up to Change the Narrative

Meharry Medical College is one of four HBCUs partnering with the American Cancer Society.

Read More

Navigating Cancer Care

Nashville startup Thyme Care is proving to be an innovator in the cancer navigation space.

Read More

ONcology Rounds

New treatments, research and leadership - Middle Tennessee has a lot going on in oncology care.

Read More

Reducing Surgical Site Infections in Orthopedic & Other Surgeries

Insights from a leading orthopedic trauma surgeon who recently visited Nashville for the Clinical Orthopaedic Society (COS) 2021 annual meeting in early November. Robert Harris, MD serves as First President-Elect for the COS.

Read More

HealthStream Preps the Workforce to Battle the Opioid Epidemic

Fanning the flames of emotional and physical pain, the global COVID-19 pandemic has added fuel to opioid use, driving the epidemic to new heights.

Read More

Fighting Addiction on All Fronts

Substance use disorder knows no racial, economic, sexual orientation, age or gender boundaries. Fighting it requires a concerted effort on all fronts.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: